SDxLabs

Equipping communities with innovative diagnostic procedures to take a proactive approach to healthcare.

[SignatureDx @Signature_Dx]

Happy Valentine's Day!

[SignatureDx @Signature_Dx]

Happy New Year from Signature!

[SDxLabs @SDx_Labs]

Wishing you and your family a happy Thanksgiving!

[SDxLabs @SDx_Labs]

1p36 deletion syndrome is a type of microdeletion caused by a missing piece of chromosome 1. Learn more about this condition and others available for screening with Prenactive™ Noninvasive Prenatal Screening Plus: https://t.co/1ffYVzolz5

[SDxLabs @SDx_Labs]

Happy Veterans Day! Thank you to all of our United States Veterans for their bravery and service to this country.

[SDxLabs @SDx_Labs]

Noninvasive Prenatal Screening (NIPS) can be done as early as 10 weeks of pregnancy and remains available through delivery. For answers to more FAQs about Prenactive™ NIPS, visit https://t.co/g1vYntKLjE

[SDxLabs @SDx_Labs]

The microdeletion syndrome caused by a deletion at 15q11.2 depends on if the deletion is on the chromosome 15 inherited from the baby’s mother (Angelman syndrome) or father (Prader-Willi syndrome). Learn more: https://t.co/1ffYVzoToD

[SDxLabs @SDx_Labs]

Noninvasive Prenatal Screening (NIPS) can detect the sex of the baby when the provider orders testing for sex chromosome aneuploidies in singleton (one baby) pregnancies. For answers to more NIPS FAQs, visit https://t.co/g1vYntKdu6

[SDxLabs @SDx_Labs]

Down Syndrome Awareness Month (DSAM) is observed every October to promote advocacy, break down barriers, and celebrate the many abilities of our loved ones with Down syndrome. Learn more from the National Down Syndrome Society: https://t.co/ibhjU2400b

#DownSyndromeAwarenessMonth

[SDxLabs @SDx_Labs]

As we continue to see heightened activity across the pharmaceutical R&D landscape, genetic testing for determining cohort inclusion plays an important role in moving clinical drug trials forward.

Learn about our clinical phenotyping services: https://t.co/R3yL379pHs

[SDxLabs @SDx_Labs]

22q11.2 deletion syndrome, also called DiGeorge syndrome, is caused by a missing piece of chromosome number 22. The majority of children with this disorder have heart defects, immune system problems, specific facial features, and learning difficulties. https://t.co/1ffYVzolz5

[SDxLabs @SDx_Labs]

It’s our 4th birthday! We are proud to celebrate 4 years here at Signature and we’re looking forward to seeing what lies ahead this next year.

[SDxLabs @SDx_Labs]

“I love being a Genetic Counselor because of the diversity which accompanies each day and the challenge to think in the context of many disciplines.”

We’re excited to introduce our newest member of the Signature team, Amanda Back!

[SDxLabs @SDx_Labs]

Prenactive™ NIPS uses a maternal blood sample, which contains a combination of both the mother's DNA and DNA from the baby. These DNA fragments are sequenced to help determine the risk for certain chromosomal abnormalities in the pregnancy. Learn more: https://t.co/g1vYntKdu6

[SDxLabs @SDx_Labs]

Wishing everyone a relaxing labor day weekend!

[SDxLabs @SDx_Labs]

We offer a variety of patient educational resources for those who are interested in learning more about noninvasive prenatal screening (NIPS) and what to expect: https://t.co/dF9wUsr1KG

[SDxLabs @SDx_Labs]

As Lead Clinical Trial Project Manager, Dan serves as the main point of contact for pharmaceutical companies and CROs who partner with SDxLabs for clinical phenotyping services. Learn more: https://t.co/R3yL379Xx0

[SDxLabs @SDx_Labs]

What does a high-risk noninvasive prenatal screening (NIPS) result mean? This video explains how to understand your new risk, possible explanations for a high-risk result, and next steps. Watch now: https://t.co/jR5F2S36KG

[SDxLabs @SDx_Labs]

A significant step in addressing maternal health disparities is understanding their social and structural determinants and how healthcare services can be tailored to meet the needs of disproportionally affected patients. Learn more: https://t.co/x7xncWyMjP

[SDxLabs @SDx_Labs]

Our core clinical phenotyping test menu includes 9 genes, including many CYP450 enzymes that play significant roles in the metabolization and elimination of common medications. Learn about our services to support clinical drug trials: https://t.co/R3yL379pHs